183 results
8-K
EX-99.2
LFCR
Lifecore Biomedical Inc
1 Apr 24
Results of Operations and Financial Condition
8:07am
. Targeted sales and marketing strategy. Identify and expand development services portfolio. Identify late-phase development and new commercial opportunities
8-K
EX-10.3
LFCR
Lifecore Biomedical Inc
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
, but no less than [* * *], to pursue a continuous improvement and competitive best practice strategy to seek ways of improving the manufacturing performance
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
31 Aug 23
Results of Operations and Financial Condition
7:39am
with five new customers, which demonstrates the impact that our expanded commercial strategy and targeted sales approach is having on our opportunity … associated with the Company's strategy to divest its Curation Foods businesses. This compares to a net loss from continuing operations of $1.0 million
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
1 Jun 23
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
7:29am
strategy to divest its Curation Foods assets. This compares to a net loss of $6.6 million in the prior year period, which includes $4.5 million
8-K
EX-99.1
tqx6v
6 Apr 23
Regulation FD Disclosure
4:10pm
8-K
EX-99.1
wk5n37ax6sw1dlc
6 Oct 22
Landec Corporation Reports First Quarter Fiscal Year 2023 Results
7:17am
8-K
EX-99.2
7yg8rqm70liyf5jre
10 Aug 22
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2022 Results
4:20pm
8-K
EX-99.3
2c4vkfxy
10 Aug 22
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2022 Results
4:20pm
8-K
EX-99.1
zanujd6cb2 vxb
10 Jan 22
Regulation FD Disclosure
8:03am
8-K
EX-99.1
i4qbww
29 Sep 21
Landec Corporation Reports First Quarter Fiscal Year 2022 Results
4:13pm
8-K
EX-99.1
rjbux0
7 Apr 21
Landec Corporation Reports Third Quarter and First Nine Months Fiscal 2021 Results
4:13pm